Clinical Trials

A011401 Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer 

BREAST CANCER WEIGHT LOSS—BWEL: This clinical trial will study whether weight loss in overweight and obese women may prevent breast cancer from recurring. (IRB#45777)

Principal Investigator: Arash Asher, MD

A Randomized Controlled Trial to Strengthen Existential Resiliency Among Women with Metastatic Cancer

GROWING RESILIENCY AND COURAGE—GRACE: This six-week clinical program covers topics such as hope, meaning, purpose, gratitude, strength, courage, perseverance, connectivity, humor and blessings on the spiritual and psychological well-being in women with metastatic cancer. (IRB#43233)

Principal Investigator: Arash Asher, MD

Microbiome, Microbial Markers and Liver Disease

A prospective observational study to measure and evaluate changes in the bodies of patients with liver cirrhosis via collection of blood samples and tissue/fluid samples from the small intestine. Participants will complete questionnaires about dietary intake, lifestyle habits, medications and medical history in order to identify associated lifestyle factors, and will be followed prospectively for outcomes including hepatocellular carcinoma. (IRB #38000)

Principal Investigator: Shehnaz Hussain, PhD

Carbohydrate and Prostate Study 3 (CAPS3): Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance

The purpose of the study is to examine the effects of a low-carbohydrate diet on the growth of prostate cancer by measuring changes in the proliferative index in biopsy tissue. (IRB#53710)

Principal Investigator: Stephen Freedland, MD